News for 'FDA'

US FDA tightens regulatory noose on Indian drug firms

US FDA tightens regulatory noose on Indian drug firms

Rediff.com17 Sep 2013

Import alert on Ranbaxy's Mohali unit; Strides' injectible arm gets warning letter

Baba Siddique: Political veteran known for grand Iftar parties

Baba Siddique: Political veteran known for grand Iftar parties

Rediff.com13 Oct 2024

Former Maharashtra minister Baba Siddique, who was shot dead in Mumbai, was a popular figure in Bollywood circles and had earned praise for supplying life-saving medicines to patients during the Covid pandemic.

Nestle India did not opt for re-test, instead burnt Maggi: FDA

Nestle India did not opt for re-test, instead burnt Maggi: FDA

Rediff.com29 Jul 2015

Maharashtra's Food and Drugs Administration on Wednesday argued in the Bombay High Court that Nestle India.

FDA warns Ranbaxy's American subsidiary

FDA warns Ranbaxy's American subsidiary

Rediff.com24 Dec 2009

The letter mentions certain cGMP violation based on site inspections conducted between July and August 2009.

US FDA to set up Indian offices by '09

US FDA to set up Indian offices by '09

Rediff.com21 Jul 2008

Under fire from some United States senators for allegedly taking lenient positions in granting product approvals to generic companies from countries like India, the US FDA is planning to speed up its plans to set up offices in India by 2009. FDA, in its latest newsletter dated July 21, has said that the agency will set up offices in Mumbai and Delhi to intensify its monitoring efforts.

Now, US FDA gets a call from Indian pharma companies

Now, US FDA gets a call from Indian pharma companies

Rediff.com27 Oct 2013

The Indian Pharmaceutical Alliance has approached regulator for a dialogue to understand the concern raised by it

FDA finds contaminated drug ingredient at GSK Ireland plant

FDA finds contaminated drug ingredient at GSK Ireland plant

Rediff.com2 Apr 2014

The FDA has stepped up its efforts to ensure drug safety in recent months.

Wockhardt hit by FDA alert on another plant

Wockhardt hit by FDA alert on another plant

Rediff.com27 Nov 2013

Its factory in Chikalthana in western India was last month hit by the British drug regulator's curb on imports from the plant over manufacturing deficiencies.

Sun Pharma hit by FDA ban on Gujarat plant, shares fall

Sun Pharma hit by FDA ban on Gujarat plant, shares fall

Rediff.com13 Mar 2014

Recently, Ranbaxy and Wockhardt too were hauled up.

Mumbai hospitals await FDA guidance on Ranbaxy drugs

Mumbai hospitals await FDA guidance on Ranbaxy drugs

Rediff.com10 Jun 2013

Earlier, Jaslok Hospital had issued an advisory to its doctors to avoid prescribing drugs manufactured by Ranbaxy.

FDA hikes fee for drug approvals, cuts unit inspection charge

FDA hikes fee for drug approvals, cuts unit inspection charge

Rediff.com5 Aug 2015

The fees for facility inspection of foreign companies have been reduced

Adulterated Drugs On Decline Amid Crackdown

Adulterated Drugs On Decline Amid Crackdown

Rediff.com10 Oct 2024

Rise in raids on illicit drug manufacturing units, alongside arrests for the production, sale, or distribution of spurious or adulterated drugs.

Aurobindo Pharma gets US FDA nod for Lamivudine

Aurobindo Pharma gets US FDA nod for Lamivudine

Rediff.com16 Jun 2005

Aurobindo Pharma on Thursday said it had received US FDA approval for anti-retroviral Lamivudine, thus enabling it to participate in the president's emergency plan for AIDS relief), a US government initiative.

After J&J, FDA puts Wipro on notice

After J&J, FDA puts Wipro on notice

Rediff.com30 Mar 2005

The Maharashtra Food and Drug Adminstration has served a notice to Wipro for allegedly "misbranding and mislabelling" its baby oil.

Oral insulin: Biocon seeks FDA nod

Oral insulin: Biocon seeks FDA nod

Rediff.com20 Apr 2005

Biotech major Biocon will file an application with the US Federal Drug Administration to begin clinical trials for oral insulin, which, it says, would be the world's first insulin that could be consumed orally.

FDA probe to tarnish our reputation: Subhiksha

FDA probe to tarnish our reputation: Subhiksha

Rediff.com8 Aug 2008

Retail chain Subhiksha feels it is being unfairly targeted by the Food and Drugs Administration (FDA) of Maharashtra in initiating enquiries and hygiene checks on grounds that it is selling repackaged goods. The company would present its case in a hearing scheduled on August 8.

It's confirmed! McDonald's India uses authentic cheese

It's confirmed! McDonald's India uses authentic cheese

Rediff.com5 Mar 2024

Westlife Foodworld, fast-food chain McDonald's operator in West and South India, on Tuesday said food safety regulator FSSAI has verified the cheese used by it and is now allowed to use the word cheese in the name of its products. Additionally, an independent NABL (National Accreditation Board for Testing and Calibration Laboratories) has also confirmed that Westlife Foodworld uses authentic cheese in its food preparation and not cheese analogues or substitutes, its managing director Saurabh Kalra said.

Keep us in loop before any FDA swoop, India tells US

Keep us in loop before any FDA swoop, India tells US

Rediff.com11 Feb 2014

Inspections only in domestic authorities' presence, visiting US drug regulator told

Lapses by some pharma cos overshadowed good things: FDA chief

Lapses by some pharma cos overshadowed good things: FDA chief

Rediff.com12 Feb 2014

On her maiden visit to India, US Food and Drug Administrator Margaret A Hamburg has said recent lapses in quality by a handful of pharma companies has overshadowed the good things done by other Indian companies, who emphasise on quality products and practices.

Dead snake found in mid-day meal packet in Sangli

Dead snake found in mid-day meal packet in Sangli

Rediff.com4 Jul 2024

A tiny dead snake was allegedly found in a packet distributed under the mid-day meal scheme meant for children aged between six months and three years at an anganwadi or a government-run nursery school in western Maharashtra's Sangli district, prompting the authorities to launch a probe.

Ranbaxy gets tentative FDA nod for drug

Ranbaxy gets tentative FDA nod for drug

Rediff.com21 Jul 2005

Ranbaxy Laboratories Ltd today said it has received tentative approval from the US Food and Drug Administration to manufacture and market Glimepiride tablets of 1 mg, 2 mg, 4 mg and 8 mg.

Dr Reddy's launches insomnia drug in US; Glenmark gets FDA nod

Dr Reddy's launches insomnia drug in US; Glenmark gets FDA nod

Rediff.com16 Apr 2014

Sunovion Pharmaceuticals Inc is the owner of the Eszopiclone drug.

FDA to prosecute Cadbury for insect infestations

FDA to prosecute Cadbury for insect infestations

Rediff.com6 Oct 2003

A report was positive for the presence of two dead and one live insect, FDA Commissioner Uttam Khobargade said in Mumbai.

India's Jaden selected for Ferrari Driver Academy trials

India's Jaden selected for Ferrari Driver Academy trials

Rediff.com16 Aug 2023

Rising Indian driver Jaden R Pariat has been invited to the Ferrari Driver Academy (FDA) selection trials.

Ranbaxy gets FDA nod for Isotretinoin capsules

Ranbaxy gets FDA nod for Isotretinoin capsules

Rediff.com23 Jun 2003

Ranbaxy Laboratories on Monday said it has received the US Food and Drug Administration's approval to manufacture and market Isotretinoin capsules, a generic version of Hoffman LaRoche's Accutane.

Mice, roaches found in food served on US airlines: FDA

Mice, roaches found in food served on US airlines: FDA

Rediff.com21 Nov 2012

In a shocker, the US Food and Drug Administration has discovered the presence of mice, ants and cockroaches in food served on airlines in the country.

India to have US FDA-like drug regulator

India to have US FDA-like drug regulator

Rediff.com23 Jun 2005

To be called Central Drug Administration or National Drug Authority, it will have 10 sub-authorities to deal with areas like cosmetics, blood safety, medical equipment, etc.

FDA asks stent makers to get DGCI approval

FDA asks stent makers to get DGCI approval

Rediff.com13 Jun 2005

Acting swiftly on the controversy regarding illegal drug-coated stents, the Maharashtra Food and Drug Administration has asked all stent manufacturers and importers to get valid licenses within the next two months from the Drugs Controller General of

US FDA likely to inspect new Visakhapatnam arm of Divi's Labs in Jan

US FDA likely to inspect new Visakhapatnam arm of Divi's Labs in Jan

Rediff.com31 Dec 2013

The move assumes significance because a go-ahead from the US Food and Drug Administration for the new unit in Visakhapatnam is likely to give a huge boost to the company's revenues in upcoming quarters.

iPhone 16 with AI steals show as Apple unveils new Airpods and watch

iPhone 16 with AI steals show as Apple unveils new Airpods and watch

Rediff.com10 Sep 2024

In a dazzling showcase at Apple Park, Apple on Monday introduced its latest technological marvels, including the much-anticipated iPhone 16 lineup. The event, held at the newly inaugurated Observatory building, featured an array of exciting updates that promise to redefine the smartphone experience.

We will regain confidence of the US FDA: Dilip Shanghvi

We will regain confidence of the US FDA: Dilip Shanghvi

Rediff.com26 Mar 2015

'The focus for value creation will be on all business segments.'

Why Is USFDA Inspecting India Pharma Firms?

Why Is USFDA Inspecting India Pharma Firms?

Rediff.com30 Dec 2022

Indian drug firms continue to work closely with the FDA, and most have also appointed consultants to help them grasp the regulatory minutiae in the US.

'US FDA not on a witch hunt against India pharma firms'

'US FDA not on a witch hunt against India pharma firms'

Rediff.com23 Sep 2013

This is not just a Ranbaxy or Wockhardt problem, says K Satish Reddy

Johnson & Johnson allowed to manufacture and sell baby powder

Johnson & Johnson allowed to manufacture and sell baby powder

Rediff.com11 Jan 2023

The Bombay high court on Wednesday permitted Johnson & Johnson to manufacture, sell and distribute its baby powder and quashed three orders of the Maharashtra government revoking the company's license and asking it to stop the product manufacture and sale, terming them as "stringent, unreasonable and unfair". A division bench of Justices Gautam Patel and S G Dige also came down heavily on the state Food and Drug Administration (FDA) for its delay in carrying out tests on a sample of the company's baby powder seized in December 2018. The bench noted that while maintaining standards of quality and safety are of utmost importance for cosmetic products, at the same time it does not seem reasonable to shut down the whole manufacturing process when there is a slight deviation in one of the products.